VSee Health, Inc. VSEED
2.28
0.48
26.67%
as of 25 Sep
- Market cap
- $2.8M
- P/E
- 0.0×
Follow VSEED
| Dec '17 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | 0.00 | 1.33 | 0.51 |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | (1,116.99) | (4.67) | (3.87) |
P/B ratio |
— | — | — | 0.00 | 0.00 | 1.37 |
Price to Tangible BV |
— | — | — | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | 0.00 | 1.36 | 0.20 |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | (192.63) | (2.45) | (0.87) |
EV/FCF |
— | — | — | (191.33) | (2.42) | (0.86) |
Quick Ratio |
— | 4.13 | 0.03 | 0.14 | 0.11 | 0.48 |
Current Ratio |
— | 6.61 | 0.03 | 0.16 | 0.16 | 0.52 |
Net Debt/EBITDA |
— | 2.69 | 0.03 | 0.07 | (0.07) | 0.67 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 2.97% | 2.65% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | (32.10) | 0.11 |
Asset Turnover |
— | 0.00 | 0.00 | 1.37 | 1.00 | 0.69 |
Operating CF/Net income |
— | 2.14 | 0.43 | 0.17 | 0.10 | 0.23 |
Capex/Depreciation |
— | — | — | (0.05) | 0.00 | (0.01) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | 60.26% | 64.18% | 2,672.63% | (541.52%) | |
| — | (0.48%) | (5.16%) | (89.17%) | (554.87%) | (69.39%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (15,581.33%) | (767.86%) |
Return on Tangible Assets |
— | (27.16%) | 101.69% | 87.52% | 376.91% | 194.96% |
Average Days of Receivables |
— | — | — | 38.20 | 60.12 | 62.94 |
Research and Development Expense of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 97.46% | 113.81% | 115.88% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.80 | 0.61 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 8.60% | 7.69% |
Graham Net Nets |
— | — | — | (0.04) | (1.22) | (1.15) |
Graham Number |
— | — | — | 1.90 | 0.47 | 0.00 |
Earnings Yield |
— | — | — | (3.05%) | (404.68%) | (197.30%) |
Free Cash Flow Yield |
— | — | — | (0.52%) | (42.08%) | (46.84%) |
Revenue per Share |
— | 0.00 | 0.00 | 0.58 | 1.02 | 0.73 |
Operating CF per Share |
— | (0.15) | (0.11) | (0.06) | (0.57) | (0.17) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | (0.01) | 0.00 |
Free Cash Flow per Share |
— | (0.15) | (0.11) | (0.06) | (0.57) | (0.17) |
Cash per Share |
— | 0.19 | 0.01 | 0.01 | 0.03 | 0.26 |
Shareholders Equity per Share |
— | (0.84) | (0.58) | (0.43) | 0.00 | 0.27 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (0.84) | (0.58) | (0.43) | 0.00 | 0.27 |
Free Cash Flow |
— | (0.60) | (1.39) | (0.64) | (5.84) | (3.48) |
Working Capital |
— | 1.03 | (3.19) | (4.30) | (15.99) | (7.88) |
Capital Expenditures |
— | — | — | 0.00 | (0.06) | (0.03) |
Net Current Asset Value |
— | (120.06) | (14.95) | (4.30) | (16.99) | (8.60) |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | 0.00 | 0.01 | 0.00 |
Net Profit Margin |
— | 0.00% | 0.00% | (65.26%) | (553.69%) | (100.65%) |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||
Depreciation/Fixed assets |
— | — | — | 25.51 | 85.36 | 7.98 |
Cash ROIC |
— | 23.31% | 19.01% | 15.22% | (717.66%) | (33.40%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 8.98 | 6.90 |
Accounts Payable Turnover |
— | — | 0.00 | 0.86 | 0.54 | 0.70 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 0.00 | 488.31 | 1,051.38 | 579.84 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | 1.16 | 2.12 |
Average Payables |
— | — | 1.01 | 2.24 | 5.97 | 10.44 |
Average Assets |
— | 58.97 | 62.79 | 4.22 | 10.40 | 21.20 |
Average Common Equity |
— | — | (5.38) | (5.86) | (2.16) | 2.72 |
Columns are period end dates